Dabibrook 150 mg (Dabigatran)

Dabibrook 150 mg contains Dabigatran, a potent oral anticoagulant used to prevent and treat blood clots and to reduce the risk of strokes in patients with non-valvular atrial fibrillation. This medication works by directly inhibiting thrombin, a key enzyme responsible for clot formation, making it highly effective in minimizing the risk of clot-related complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Recommended for twice-daily use, Dabibrook 150 mg provides a convenient alternative to traditional therapies like warfarin, with no need for routine INR monitoring. It is also used in patients undergoing hip or knee replacement surgery to prevent post-operative clots. Patients should take this medication exactly as prescribed and avoid stopping it suddenly without medical advice, as this could increase the risk of stroke. Common side effects may include bleeding, indigestion, or abdominal discomfort. Patients with kidney problems should consult their doctor for proper dose adjustments. Overall, Dabibrook 150 mg delivers effective, consistent anticoagulation for high-risk individuals.